Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy
Wenjie Zhai, Xiuman Zhou, Mingxia Zhai, Wanqiong Li, Yunhui Ran, Yixuan Sun, Jiangfeng Du, Wenshan Zhao, Lingxiao Xing, Yuanming Qi, Yanfeng Gao
Topics & Concepts
ImmunotherapyBlocking (statistics)Cancer immunotherapyCyclic peptidePeptideCancerCancer researchPD-L1ChemistryPharmacologyMedicineInternal medicineBiochemistryComputer scienceComputer networkCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionImmunotherapy and Immune Responses